Skip to content

Efficacy of combined soluble dietary fiebers based on standard triple therapy on Helicobacter Pylori eradication in children:A randomized, double-blind, placebo-controlled, add-on design, single-center, pilot study

Efficacy of combined soluble dietary fiebers based on standard triple therapy on Helicobacter Pylori eradication in children:A randomized, double-blind, placebo-controlled, add-on design, single-center, pilot study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022820
Enrollment
Unknown
Registered
2019-04-27
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori Infection

Interventions

Experimental group:Combined soluble dietary fibers was added on the basis of standard triad

Sponsors

Baoding Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1.4-16 years old, gender not limited; 2.Children diagnosed with Helicobacter Pylori infection with obvious gastrointestinal symptoms.

Exclusion criteria

Exclusion criteria: 1. There are contraindications to do endoscopic examination; 2. Patients with serious diseases of the cardiopulmonary, blood, liver and kidney, and nervous system; 3. Patients with a history of allergy to any of the drug ingredients in the trial; 4. Patients who are unwilling to participate in or unable to cooperate in this study; 5. Patients are on Drugs (e.g. PPI, H2 receptor blocker, bismuth agent or antibiotic, probiotics, etc.) that may affect the results of the study were taken 2-4 weeks before enrollment; 6. The patient was diagnosed with peptic ulcer or complicated hemorrhage; 7. Patients undergoing digestive tract surgery.

Design outcomes

Primary

MeasureTime frame
Hp eradication rate;

Secondary

MeasureTime frame
Hp recurernce rate;analyse of intestinal flora diversity;symptoms;compliance;adverse event;

Countries

China

Contacts

Public ContactQingwei Dong, Songsong Chen

Baoding Children's Hospital

tjj604@126.com+86 13903228877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026